Oxadiazole derivatives: Histone deacetylase inhibitors in anticancer therapy and drug discovery
Heterocycles are being playing an important role in cancer treatment for years. Currently, a number of anticancer agents are available on market, but concerns such as less effectiveness, drug resistance, adverse effects, and non-selectivity create an urgent need for the development of newer highly p...
Saved in:
Main Authors: | Balaji Wamanrao Matore (Author), Purusottam Banjare (Author), Tanmoy Guria (Author), Partha Pratim Roy (Author), Jagadish Singh (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thiazolidinedione an auspicious scaffold as PPAR-γ agonist: its possible mechanism to Manoeuvre against insulin resistant diabetes mellitus
by: Sourav Basak, et al.
Published: (2024) -
Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
by: Yiming Chen, et al.
Published: (2021) -
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020) -
Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
by: Wenli Fan, et al.
Published: (2021) -
Clinical Toxicities of Histone Deacetylase Inhibitors
by: Richard L. Piekarz, et al.
Published: (2010)